These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 880876)

  • 21. Naltrexone in a behavioral treatment program.
    O'Brien C; Greenstein R
    NIDA Res Monogr; 1976 Sep; (9):136-40. PubMed ID: 63915
    [No Abstract]   [Full Text] [Related]  

  • 22. Patient response to naltrexone: issues of acceptance, treatment effects, and frequency of administration.
    Curran S; Savage C
    NIDA Res Monogr; 1976 Sep; (9):67-9. PubMed ID: 794722
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical experience with naltrexone in a behavioral research study: an interim report.
    Greenstein R; O'Brien C; Mintz J; Woody G; Hanna N
    NIDA Res Monogr; 1976 Sep; (9):141-9. PubMed ID: 794715
    [No Abstract]   [Full Text] [Related]  

  • 24. The index of choice: indications of methadone patients' selection of naltrexone treatment.
    Singleton EG; Sherman MF; Bigelow GE
    Am J Drug Alcohol Abuse; 1984; 10(2):209-21. PubMed ID: 6475888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of drugs in urine for methadone treatment programs.
    Baselt RC; Casarett LJ
    J Chromatogr; 1971 Apr; 57(1):139-41. PubMed ID: 5103555
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical experience with naltrexone.
    O'Brien CP; Greenstein RA; Mintz J; Woody GE
    Am J Drug Alcohol Abuse; 1975; 2(3-4):365-77. PubMed ID: 1227298
    [No Abstract]   [Full Text] [Related]  

  • 27. Buprenorphine and naloxone interactions in methadone maintenance patients.
    Mendelson J; Jones RT; Welm S; Brown J; Batki SL
    Biol Psychiatry; 1997 Jun; 41(11):1095-101. PubMed ID: 9146820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction.
    Simon DL
    Conn Med; 1996 Nov; 60(11):683-5. PubMed ID: 8979434
    [No Abstract]   [Full Text] [Related]  

  • 29. The naloxone test for opiate dependence.
    Judson BA; Himmelberger DU; Goldstein A
    Clin Pharmacol Ther; 1980 Apr; 27(4):492-501. PubMed ID: 7357808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naltrexone: the clinical investigator's dilemma.
    Ling W
    NIDA Res Monogr; 1978; (19):308-14. PubMed ID: 106297
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical implications of urine surveillance in a methadone maintenance program.
    Nightingale SL; Michaux WW; Platt PC
    Int J Addict; 1972; 7(3):403-14. PubMed ID: 5085274
    [No Abstract]   [Full Text] [Related]  

  • 32. [Naltrexone in the therapeutic relation in cases of opioid abuse and dependence].
    Liffredo C; Gallino G
    Minerva Med; 1993 Dec; 84(12):687-92. PubMed ID: 8127459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Narcotic antagonist treatment of the criminal justice patient-institutional vs outpatient-including a 24 hour detox naltrexone induction regimen with oral medication.
    Brahen L; Wiechert V; Capone T
    NIDA Res Monogr; 1976 Sep; (9):93-8. PubMed ID: 794727
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacotherapy of opiate addiction.
    Swanson DA
    S Afr Med J; 1976 May; 50(22):857-9. PubMed ID: 935974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methadone and naltrexone in the treatment of heroin dependence.
    Greenstein RA; Resnick RB; Resnick E
    Psychiatr Clin North Am; 1984 Dec; 7(4):671-9. PubMed ID: 6522309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The sequential use of clonidine and naltrexone in the treatment of opiate addicts.
    Gold MS; Dackis CA; Washton AM
    Adv Alcohol Subst Abuse; 1984; 3(3):19-39. PubMed ID: 6388273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapy for Substance Use Disorders.
    Klein JW
    Med Clin North Am; 2016 Jul; 100(4):891-910. PubMed ID: 27235620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacotherapeutic environments for substance use disorders.
    Gardner TJ; Kosten TR
    Am J Drug Alcohol Abuse; 2007; 33(5):627-9. PubMed ID: 17891655
    [No Abstract]   [Full Text] [Related]  

  • 39. Drugs of abuse--opiates.
    Ling W; Wesson DR
    West J Med; 1990 May; 152(5):565-72. PubMed ID: 2161588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological treatments for substance use disorders.
    Bailey KP
    J Psychosoc Nurs Ment Health Serv; 2004 Aug; 42(8):14-20. PubMed ID: 15354595
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.